Skip to main content
Top
Published in: Trials 1/2020

Open Access 01-12-2020 | Research

Challenges in the design, planning and implementation of trials evaluating group interventions

Authors: Katie Biggs, Daniel Hind, Rebecca Gossage-Worrall, Kirsty Sprange, David White, Jessica Wright, Robin Chatters, Katherine Berry, Diana Papaioannou, Mike Bradburn, Stephen J. Walters, Cindy Cooper

Published in: Trials | Issue 1/2020

Login to get access

Abstract

Background

Group interventions are interventions delivered to groups of people rather than to individuals and are used in healthcare for mental health recovery, behaviour change, peer support, self-management and/or health education. Evaluating group interventions in randomised controlled trials (RCTs) presents trialists with a set of practical problems, which are not present in RCTs of one-to-one interventions and which may not be immediately obvious.

Methods

Case-based approach summarising Sheffield trials unit’s experience in the design and implementation of five group interventions. We reviewed participant recruitment and attrition, facilitator training and attrition, attendance at the group sessions, group size and fidelity aspects across five RCTs.

Results

Median recruitment across the five trials was 3.2 (range 1.7–21.0) participants per site per month. Group intervention trials involve a delay in starting the intervention for some participants, until sufficient numbers are available to start a group. There was no evidence that the timing of consent, relative to randomisation, affected post-randomisation attrition which was a matter of concern for all trial teams. Group facilitator attrition was common in studies where facilitators were employed by the health system rather than the by the grant holder and led to the early closure of one trial; research sites responded by training ‘back-up’ and new facilitators. Trials specified that participants had to attend a median of 62.5% (range 16.7%–80%) of sessions, in order to receive a ‘therapeutic dose’; a median of 76.7% (range 42.9%–97.8%) received a therapeutic dose. Across the five trials, 75.3% of all sessions went ahead without the pre-specified ideal group size. A variety of methods were used to assess the fidelity of group interventions at a group and individual level across the five trials.

Conclusion

This is the first paper to provide an empirical basis for planning group intervention trials. Investigators should expect delays/difficulties in recruiting groups of the optimal size, plan for both facilitator and participant attrition, and consider how group attendance and group size affects treatment fidelity.

Trial registration

ISRCTN17993825 registered on 11/10/2016, ISRCTN28645428 registered on 11/04/2012, ISRCTN61215213 registered on 11/05/2011, ISRCTN67209155 registered on 22/03/2012, ISRCTN19447796 registered on 20/03/2014.
Literature
3.
go back to reference Hind D, Mountain G, Gossage-Worrall R, Walters SJ, Duncan R, Newbould L, et al. Putting Life in Years (PLINY): a randomised controlled trial and mixed-methods process evaluation of a telephone friendship intervention to improve mental well-being in independently living older people. Public Heal Res. 2014;2:1–222. https://doi.org/10.3310/phr02070.CrossRef Hind D, Mountain G, Gossage-Worrall R, Walters SJ, Duncan R, Newbould L, et al. Putting Life in Years (PLINY): a randomised controlled trial and mixed-methods process evaluation of a telephone friendship intervention to improve mental well-being in independently living older people. Public Heal Res. 2014;2:1–222. https://​doi.​org/​10.​3310/​phr02070.CrossRef
4.
go back to reference Heller S, White D, Lee E, Lawton J, Pollard D, Waugh N, et al. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: The REPOSE Trial. Health Technol Assess (Rockv). 2017;21:1–277.CrossRef Heller S, White D, Lee E, Lawton J, Pollard D, Waugh N, et al. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: The REPOSE Trial. Health Technol Assess (Rockv). 2017;21:1–277.CrossRef
5.
go back to reference Holt RIG, Gossage-Worrall R, Hind D, Bradburn MJ, McCrone P, Morris T, et al. Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial. Br J Psychiatry. 2019;214:63–73.PubMedPubMedCentralCrossRef Holt RIG, Gossage-Worrall R, Hind D, Bradburn MJ, McCrone P, Morris T, et al. Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial. Br J Psychiatry. 2019;214:63–73.PubMedPubMedCentralCrossRef
6.
go back to reference Yalom ID, Leszcz M. The theroy and practice of group psychotherapy. 5th ed. New York: Basic Books; 2005. Yalom ID, Leszcz M. The theroy and practice of group psychotherapy. 5th ed. New York: Basic Books; 2005.
7.
go back to reference Borek AJ, Abraham C. How do Small Groups Promote Behaviour Change? An Integrative Conceptual Review of Explanatory Mechanisms. Appl Psychol Heal Well Being. 2018;10:30–61.CrossRef Borek AJ, Abraham C. How do Small Groups Promote Behaviour Change? An Integrative Conceptual Review of Explanatory Mechanisms. Appl Psychol Heal Well Being. 2018;10:30–61.CrossRef
9.
go back to reference Corsini RJ, Rosenberg B. Mechanisms of group psychotherapy: Processes and dynamics. J Abnorm Soc Psychol. 1955;51:406–11.CrossRef Corsini RJ, Rosenberg B. Mechanisms of group psychotherapy: Processes and dynamics. J Abnorm Soc Psychol. 1955;51:406–11.CrossRef
10.
12.
go back to reference Huebner RA. Group procedures. In: Chan F, Berven NL, Thomas KR, editors. Counseling theories and techniques for rehabilitation health professionals. New York: Springer; 2004. p. 244–63. Huebner RA. Group procedures. In: Chan F, Berven NL, Thomas KR, editors. Counseling theories and techniques for rehabilitation health professionals. New York: Springer; 2004. p. 244–63.
38.
go back to reference Hollon SD, Shaw BF. Group Cognitive Therapy for Depressed Patients. In: Beck AT, Rush AJ, Shaw BF, Emery G, editors. Cognitive therapy of depression. New York: Guilford Press; 1979. p. 328–53. Hollon SD, Shaw BF. Group Cognitive Therapy for Depressed Patients. In: Beck AT, Rush AJ, Shaw BF, Emery G, editors. Cognitive therapy of depression. New York: Guilford Press; 1979. p. 328–53.
42.
go back to reference Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and evaluating complex interventions: new guidance. London: MRC; 2008. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and evaluating complex interventions: new guidance. London: MRC; 2008.
44.
go back to reference Flyvbjerg B. Curbing Optimism Bias and Strategic Misrepresentation in Planning: Reference Class Forecasting in Practice. Eur Plan Stud. 2008;16:3–21.CrossRef Flyvbjerg B. Curbing Optimism Bias and Strategic Misrepresentation in Planning: Reference Class Forecasting in Practice. Eur Plan Stud. 2008;16:3–21.CrossRef
51.
go back to reference Palmer R, Harrison M, Cross E, Enderby P. Negotiating excess treatment costs in a clinical research trial: the good, the bad and the innovative. Trials. 2016;17:71.PubMedPubMedCentralCrossRef Palmer R, Harrison M, Cross E, Enderby P. Negotiating excess treatment costs in a clinical research trial: the good, the bad and the innovative. Trials. 2016;17:71.PubMedPubMedCentralCrossRef
52.
go back to reference Simmons T. Attributing the costs of health and social care Research & Development (AcoRD). London: Department of Health; 2012. Simmons T. Attributing the costs of health and social care Research & Development (AcoRD). London: Department of Health; 2012.
53.
go back to reference Lenney W, Perry S, Price D. Clinical trials and tribulations: the MASCOT study. Thorax. 2011;66:457–8.PubMedCrossRef Lenney W, Perry S, Price D. Clinical trials and tribulations: the MASCOT study. Thorax. 2011;66:457–8.PubMedCrossRef
54.
go back to reference Snooks H, Hutchings H, Seagrove A, Stewart-Brown S, Williams J, Russell I. Bureaucracy stifles medical research in Britain: a tale of three trials. BMC Med Res Methodol. 2012;12:122.PubMedPubMedCentralCrossRef Snooks H, Hutchings H, Seagrove A, Stewart-Brown S, Williams J, Russell I. Bureaucracy stifles medical research in Britain: a tale of three trials. BMC Med Res Methodol. 2012;12:122.PubMedPubMedCentralCrossRef
57.
go back to reference Linnan L, Steckler A. Process evaluation for public health interventions and research: an overview. In: Linnan L, Steckler A, editors. Process evaluation for public health interventions and research. 1st ed. San Francisco: Jossey-Bass; 2002. p. 1–23. Linnan L, Steckler A. Process evaluation for public health interventions and research: an overview. In: Linnan L, Steckler A, editors. Process evaluation for public health interventions and research. 1st ed. San Francisco: Jossey-Bass; 2002. p. 1–23.
59.
go back to reference Murray E, Treweek S, Pope C, MacFarlane A, Ballini L, Dowrick C, et al. Normalisation process theory: a framework for developing, evaluating and implementing complex interventions. BMC Med. 2010;8:63.PubMedPubMedCentralCrossRef Murray E, Treweek S, Pope C, MacFarlane A, Ballini L, Dowrick C, et al. Normalisation process theory: a framework for developing, evaluating and implementing complex interventions. BMC Med. 2010;8:63.PubMedPubMedCentralCrossRef
61.
go back to reference Walters SJ. Therapist effects in randomised controlled trials: What to do about them. J Clin Nurs. 2010;19:1102–12.PubMedCrossRef Walters SJ. Therapist effects in randomised controlled trials: What to do about them. J Clin Nurs. 2010;19:1102–12.PubMedCrossRef
64.
go back to reference Campbell M, Walters S. How to design, analyse and report cluster randomised trials in medicine and health related research. Chichester: Wiley; 2014.CrossRef Campbell M, Walters S. How to design, analyse and report cluster randomised trials in medicine and health related research. Chichester: Wiley; 2014.CrossRef
66.
go back to reference Ukoumunne OC, Gulliford MC, Chinn S, Sterne JA, Burney PG. Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technol Assess. 1999;3:iii–92.PubMedCrossRef Ukoumunne OC, Gulliford MC, Chinn S, Sterne JA, Burney PG. Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review. Health Technol Assess. 1999;3:iii–92.PubMedCrossRef
67.
go back to reference Walters SJ, Bonacho dos Anjos Henriques-Cadby I, Bortolami O, Flight L, Hind D, Jacques RM, et al. Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme. BMJ Open. 2017;7:e015276.PubMedPubMedCentralCrossRef Walters SJ, Bonacho dos Anjos Henriques-Cadby I, Bortolami O, Flight L, Hind D, Jacques RM, et al. Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme. BMJ Open. 2017;7:e015276.PubMedPubMedCentralCrossRef
68.
go back to reference Mountain GA, Hind D, Gossage-Worrall R, Walters SJ, Duncan R, Newbould L, et al. “Putting Life in Years” (PLINY) telephone friendship groups research study: pilot randomised controlled trial. Trials. 2014;15:141.PubMedPubMedCentralCrossRef Mountain GA, Hind D, Gossage-Worrall R, Walters SJ, Duncan R, Newbould L, et al. “Putting Life in Years” (PLINY) telephone friendship groups research study: pilot randomised controlled trial. Trials. 2014;15:141.PubMedPubMedCentralCrossRef
70.
go back to reference Pfadenhauer LM, Mozygemba K, Gerhardus A, Hofmann B, Booth A, Lysdahl KB, et al. Context and implementation: A concept analysis towards conceptual maturity. Z Evid Fortbild Qual Gesundhwes. 2015;109:103–14.PubMedCrossRef Pfadenhauer LM, Mozygemba K, Gerhardus A, Hofmann B, Booth A, Lysdahl KB, et al. Context and implementation: A concept analysis towards conceptual maturity. Z Evid Fortbild Qual Gesundhwes. 2015;109:103–14.PubMedCrossRef
71.
go back to reference Spilker B, Cramer JA. A frame of reference for patient recruitment Issues. In: Patient Recruitment in Clinical Trials. New York: Raven; 1991. p. 3–23. Spilker B, Cramer JA. A frame of reference for patient recruitment Issues. In: Patient Recruitment in Clinical Trials. New York: Raven; 1991. p. 3–23.
72.
go back to reference Stein REK, Bauman LJ, Ireys HT. Who enrolls in prevention trials? Discordance in perception of risk by professionals and participants. Am J Community Psychol. 1991;19:603–17.PubMedCrossRef Stein REK, Bauman LJ, Ireys HT. Who enrolls in prevention trials? Discordance in perception of risk by professionals and participants. Am J Community Psychol. 1991;19:603–17.PubMedCrossRef
73.
74.
go back to reference Nager AL, Khanna K. Emergency Department Surge: Models and Practical Implications. J Trauma Inj Infect Crit Care. 2009;67(Supplement):S96–9.CrossRef Nager AL, Khanna K. Emergency Department Surge: Models and Practical Implications. J Trauma Inj Infect Crit Care. 2009;67(Supplement):S96–9.CrossRef
75.
go back to reference Vanderby S, Carter MW. An evaluation of the applicability of system dynamics to patient flow modelling. J Oper Res Soc. 2010;61:1572–81.CrossRef Vanderby S, Carter MW. An evaluation of the applicability of system dynamics to patient flow modelling. J Oper Res Soc. 2010;61:1572–81.CrossRef
76.
go back to reference Watson SK, Rudge JW, Coker R. Health Systems’ “Surge Capacity”: State of the Art and Priorities for Future Research. Milbank Q. 2013;91:78–122.PubMedPubMedCentralCrossRef Watson SK, Rudge JW, Coker R. Health Systems’ “Surge Capacity”: State of the Art and Priorities for Future Research. Milbank Q. 2013;91:78–122.PubMedPubMedCentralCrossRef
77.
go back to reference Schulz KF, Grimes DA. Sample size slippages in randomised trials: Exclusions and the lost and wayward. Lancet. 2002;359:781–5.PubMedCrossRef Schulz KF, Grimes DA. Sample size slippages in randomised trials: Exclusions and the lost and wayward. Lancet. 2002;359:781–5.PubMedCrossRef
78.
79.
go back to reference Hawe P. Lessons from complex interventions to improve health. Annu Rev Public Health. 2015;36:307–23.PubMedCrossRef Hawe P. Lessons from complex interventions to improve health. Annu Rev Public Health. 2015;36:307–23.PubMedCrossRef
80.
go back to reference Bellg AJ, Resnick B, Minicucci DS, Ogedegbe G, Ernst D, Borrelli B, et al. Enhancing treatment fidelity in health behavior change studies: Best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004;23:443–51.PubMedCrossRef Bellg AJ, Resnick B, Minicucci DS, Ogedegbe G, Ernst D, Borrelli B, et al. Enhancing treatment fidelity in health behavior change studies: Best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004;23:443–51.PubMedCrossRef
81.
go back to reference Holt RIG, Pendlebury J, Wildgust HJ, Bushe CJ. Intentional weight loss in overweight and obese patients with severe mental illness: 8-year experience of a behavioral treatment program. J Clin Psychiatry. 2010;71:800–5.PubMedCrossRef Holt RIG, Pendlebury J, Wildgust HJ, Bushe CJ. Intentional weight loss in overweight and obese patients with severe mental illness: 8-year experience of a behavioral treatment program. J Clin Psychiatry. 2010;71:800–5.PubMedCrossRef
84.
go back to reference Tudor Smith C, Hopkins C, Sydes MR, Woolfall K, Clarke M, Murray G, et al. How should individual participant data (IPD) from publicly funded clinical trials be shared? BMC Med. 2015;13:298.CrossRef Tudor Smith C, Hopkins C, Sydes MR, Woolfall K, Clarke M, Murray G, et al. How should individual participant data (IPD) from publicly funded clinical trials be shared? BMC Med. 2015;13:298.CrossRef
Metadata
Title
Challenges in the design, planning and implementation of trials evaluating group interventions
Authors
Katie Biggs
Daniel Hind
Rebecca Gossage-Worrall
Kirsty Sprange
David White
Jessica Wright
Robin Chatters
Katherine Berry
Diana Papaioannou
Mike Bradburn
Stephen J. Walters
Cindy Cooper
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Trials / Issue 1/2020
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-019-3807-4

Other articles of this Issue 1/2020

Trials 1/2020 Go to the issue